» Articles » PMID: 32368086

Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 May 6
PMID 32368086
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Ten-eleven translocation (TET) enzymes that oxidize a 5-methylcytosine (5mC) to yield 5-hydroxymethylcytosine (5hmC) have been responsible for fine-tuning methylation patterns and exhibit role in epigenetic modifications. Chrysin, a natural flavone frequently present in honey, has been recognized to exhibit anti-tumor properties. In this study, we investigated the effects of Chrysin in the expression pattern of TET proteins in gastric cancer (GC) cells.

Materials And Methods: Using qRT-PCR and Western blot analysis, we analyzed the expression of TET1 in GC cells in vitro following treatment with Chrysin. Immunofluorescence staining detected the expression levels of 5mC and 5hmC. Flow cytometry, wound healing, and Matrigel invasion assays were performed to determine cell proliferation, cell cycle, apoptosis, and migration and invasion of GC cells following treatment with Chrysin, si-TET1, and TET1-KO. Furthermore, a xenograft model was developed to analyze the expression pattern of TET1 on tumor development in vivo.

Results: qRT-PCR and Western blot assays indicated that treatment with Chrysin significantly promoted the expression of TET1 in GC cells. Immunofluorescence study further confirmed that TET1 and 5hmC levels were significantly enhanced following treatment with Chrysin in MKN45 cells. Moreover, our results suggested that Chrysin could noticeably induce cell apoptosis and inhibit cell migration and invasion. Further, knockdown and overexpression of TET1 were conducted to investigate whether TET1 expression affected cell apoptosis, and cell migration and invasion in MKN45 cells. The results indicated that overexpression of TET1 markedly promoted cell apoptosis and inhibited cell migration and invasion. Furthermore, the TET1 gene knocked out was generated using the CRISPR/Cas9 system. Our data suggested that TET1 expression was associated with GC tumor growth in vivo.

Conclusion: This study indicated that Chrysin exerted anti-tumor effects through the regulation of TET1 expression in GC and presented TET1 as a novel promising therapeutic target for GC therapy.

Citing Articles

Anticancer Activity of Ether Derivatives of Chrysin.

Sokal A, Mruczek P, Niedoba M, Dewalska A, Stocerz K, Kadela-Tomanek M Molecules. 2025; 30(4).

PMID: 40005270 PMC: 11857933. DOI: 10.3390/molecules30040960.


Research Progress of in the Treatment of Gastrointestinal Cancer.

Wang L, Ni B, Wang J, Zhou J, Wang J, Jiang J Integr Cancer Ther. 2024; 23:15347354241302049.

PMID: 39610320 PMC: 11605761. DOI: 10.1177/15347354241302049.


Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance.

Cai J, Tan X, Hu Q, Pan H, Zhao M, Guo C Drug Des Devel Ther. 2024; 18:3233-3253.

PMID: 39081701 PMC: 11287762. DOI: 10.2147/DDDT.S466470.


Total Flavonoids in L. and Evaluation of Its Anticancer Activity.

He M, Yasin K, Yu S, Li J, Xia L Int J Mol Sci. 2023; 24(22).

PMID: 38003540 PMC: 10671751. DOI: 10.3390/ijms242216348.


Co-administration of Chrysin and Luteolin with Cisplatin and Topotecan Exhibits a Variable Therapeutic Value in Human Cancer Cells, HeLa.

Raina R, Hussain A, Almutary A, Haque S, Raza T, DSouza A ACS Omega. 2023; 8(44):41204-41213.

PMID: 37970041 PMC: 10633856. DOI: 10.1021/acsomega.3c04443.


References
1.
Guo H, Zhu H, Zhang J, Wan B, Shen Z . TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway. J Cell Biochem. 2019; 120(8):12559-12565. DOI: 10.1002/jcb.28522. View

2.
Zhang C, Yu W, Huang C, Ding Q, Liang C, Wang L . Chrysin protects human osteoarthritis chondrocytes by inhibiting inflammatory mediator expression via HMGB1 suppression. Mol Med Rep. 2018; 19(2):1222-1229. DOI: 10.3892/mmr.2018.9724. View

3.
Du C, Kurabe N, Matsushima Y, Suzuki M, Kahyo T, Ohnishi I . Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer. Gastric Cancer. 2014; 18(3):516-25. DOI: 10.1007/s10120-014-0409-4. View

4.
Mohammadian F, Pilehvar-Soltanahmadi Y, Alipour S, Dadashpour M, Zarghami N . Chrysin Alters microRNAs Expression Levels in Gastric Cancer Cells: Possible Molecular Mechanism. Drug Res (Stuttg). 2017; 67(9):509-514. DOI: 10.1055/s-0042-119647. View

5.
Huang Y, Rao A . Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 2014; 30(10):464-74. PMC: 4337960. DOI: 10.1016/j.tig.2014.07.005. View